Summary
-
1.
Hereditary spastic paraplegia (HSP) is a genetically heterogeneous group of neurodegenerative disorders affecting 1 in 10,000 individuals. The present study was aimed to elucidate the role played by reactive oxygen species (ROS) in the pathogenesis of this disease.
-
2.
To address this question we used 7–11 passaged fibroblasts from HSP patients to measure the extent of DNA damage induced by H2O2 treatment and to evaluate the JNK phosphorylation level after hydrogen peroxide and serum stimuli.
-
3.
The present study demonstrates that HSP cells compared to controls are more sensitive to DNA damages induced by H2O2 treatment, and that JNK phosphorylation levels are increased in HSP fibroblasts compared to controls after hydrogen peroxide and serum stimuli. These results suggest a ROS-mediated pathogenetic mechanism for this disease.
Similar content being viewed by others
References
Adler, V., Yin, Z., Fuchs, S. Y., Benezra, M., Rosario, L., Tew, K. D., Pincus, M. R., Sardana, M., Henderson, C. J., Wolf, C. R., Davis, R. J., and Ronai, Z. (1999). Regulation of JNK signaling by GSTp. EMBO J. 18:1321–1334.
Atorino, L., Silvestri, L., Koppen, M., Cassina, L., Ballabio, A., Marconi, R., Langer, T., and Casari, G. (2003). Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J. Cell. Biol. 163:777–787.
Barrientos, A., and Moraes, C. T. (1999). Titrating the effects of mitochondrial complex I impairment in the cell physiology. J. Biol. Chem. 274:16188–16197.
Behan, W., and Maia, M. (1974). Strumpell's familial spastic paraplegia: Genetics and neuropathy. J. Neurol. Neurosurg. Psychiatry 37:8–20.
Casari, G., De Fusco, M., Ciarmatori, S., Zeviani, M., Mora, M., Fernandez, P., De Michele, G., Filla, A., Cocozza, S., Marconi, R., Durr, A., Fontaine, B., and Ballabio, A. (1998). Spastic paraplegia and oxphos impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 93:973–983.
Dizdaroglu, M. (1992). Oxidative damage to DNA in mammalian chromatin. Mutat. Res. 275:331–342.
Facchinetti, F., Dawson, V., and Dawson, T. (1998). Free radicals as mediators of neuronal injury. Cell. Mol. Neurobiol. 18:667–682.
Ferreirinha, F., Quattrini, A., Pirozzi, M., Valsecchi, V., Dina, G., Broccoli, V., Auricchio, A., Piemonte, F., Tozzi, G., Gaeta, L., Casari, G., Ballabio, A., and Rugarli, E. I. (2004). Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. 113:231–242.
Filla, A., De Michele, G., Marconi, R., Bucci, L., Carillo, C., Castellano, A. E., Iorio, L., Kniahynicki, C., Rossi, F., and Campanella, G. (1992). Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy. J. Neurol. 239:351–353.
Finkel, T. (2000). Redox-dependent signal tranduction. FEBS Lett. 476:52–54.
Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. (1998a). MEKK1/JNK stabilizes and activates p53. Proc. Natl. Acad. Sci. U.S.A. 95:10541–10546.
Fuchs, S. Y., Adler, V., Buschmann, T., Yin, Z., Wu, X., Jones, S. T., and Ronai, Z. (1998b). JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev. 12:2658–2663.
Ham, J., Eilers, A., Whitfield, J., Neame, S. J., and Shah, B. (2000). c-Jun and transcriptional control of neuronal apoptosis. Biochem. Pharmacol. 60:1015–1021.
Harangi, M., Remenyik, E., Seres, I., Varga, Z., Catona, E., and Paragh, G. (2002). Determination of DNA damage induced by oxidative stress in hyperlipidemic patients. Mutat. Res. 513:17–25.
Kan, E., Undeger, U., Bali, M., and Basaran, N. (2002). Assessment of DNA strand breakage by the alkaline comet assay in dialysis patients and the role of Vitamin E supplementation. Mutat. Res. 520:151–159.
Karin, M. (1995). The regulation of AP-1 activity by mitogen activated protein kinases. J. Biol. Chem. 270:16483–16486.
Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., Green, M., and Douglas, R. (1998). DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kB and AP-1. Mol. Cell. 1:543–551.
Kassie, F., Parzefall, W., and Knasmuller, S. (2000). Single cell gel electrophoresis assay: A new technique for human biomonitoring studies. Mutat. Res. 463:13–31.
Kisby, G. E., Kabel, H., Hugon, J., and Spencer, P. (1999). Damage and repair of nerve cell DNA in toxic stress. Drug Metab. Rev. 31:589–618.
Kyriakis, J. M., and Avruch, J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807–869.
Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., and Avruch, J. (1994). The stress-activated protein kinase subfamily of c-jun kinases. Nature 369:156–160.
Li, N., Ragheb, K., Lawler, G., Sturgis, J., Rajwa, B., Melendez, J. A., and Robinson, J. P. (2003). Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 278:8516–8525.
Lovell, M., Gabbita, S., and Markesbery, W. (1999). Increased DNA oxidation, and decreased levels of repair products in Alzheimer's disease ventricular CSF. J. Neurochem. 72:771–776.
Martin, L. J. (2001). Neuronal cell death in nervous system development, disease, and injury. Int. J. Mol. Med. 7:455–478.
Mc Dermott, C., White, K., Bushby, K., and Shaw, P. (2000). Hereditary spastic paraparesis: A review of new developments. J. Neurol. Neurosurg. Psychiatry 69:150–160.
Mecocci, P., Fano, G., Fulle, S., Macgarvey, U., Shinobu, L., Polidori, M., Cherubini, A., Vecchiet, J., Senin, U., and Beal, M. (1999). Age-dependent increases in oxidative damage to DNA, lipids, and proteins in human skeletal muscle. Free Radic. Biol. Med. 26:303–308.
Minden, A., Lin, A., McMahon, M., Lange-Carter, C., Derijard, B., Davis, R. J., Johnson, G. L., and Karin, M. (1994). Differential activation of ERK and JNK mitogen-activated protein kinases by Raf-1 and MEKK. Science 266:1719–1723.
Patel, S., and Latterich, M. (1998). The AAA team: Related ATPases with diverse functions. Trends Cell. Biol. 8:65–71.
Paul, A., Wilson, S., Belhaman, C. M., Robinson, K. J. M., Scott, P. H., Gould, G. W., and Plevin, R. (1997). Stress-activated protein kinases: Activation, regulation, and function. Cell. Signal. 9:403–410.
Pianese, L., Busino, L., De Biase, I., De Cristofaro, T., Lo Casale, M. S., Giuliano, P., Monticelli, A., Turano, M., Criscuolo, C., Filla, A., Varrone, S., and Cocozza, S. (2002). Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. Hum. Mol. Genet. 11:2989–2996.
Polo, J. M., Calleja, J., Combarros, O., and Berciano, J. (1993). Hereditary “pure” spastic paraplegia: A study of nine families. J. Neurol. Neurosurg. Psychiatry 56:175–181.
Reid, E. (2003). Many pathways lead to hereditary spastic paraplegia. Lancet Neurol. 2:210.
Rep, M., and Grivell, L. A. (1996). The role of protein degradation in mitochondrial function and biogenesis. Curr. Genet. 30:367–380.
Richter, C., Park, J., and Arnes, B. (1988). Normal oxidative damage to mitochondrial and nuclear DNA is extensive. Proc. Natl. Acad. Sci. U.S.A. 85:6465–6467.
Ristow, M., Pfister, M. F., Yee, A. J., Schubert, M., Michael, L., Zhang, C. Y., Ueki, K., Michael, M. D., Lowell, B. B., and Kahn, C. R. (2000). Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 97:12239–12243.
Sardas, S., Yilmaz, M., Oztok, U., Cakir, N., and Karakaya, A. E. (2001). Assessment of DNA strand breakage by comet assay in diabetic patients and the role of antioxidant supplementation. Mutat. Res. 490:123–129.
Schapira, A. H., Cooper, J. M., Dexter, D., Clark, J. B., Jenner, P., and Marsden, C. D. (1990). Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54:823–827.
Schulz, J. B., Dehmer, T., Schols, L., Mende, H., Hardt, C., Vorgerd, M., Burk, K., Matson, W., Dichgans, J., Beal, M. F., and Bogdanov, M. B. (2000). Oxidative stress in patients with Friedreich ataxia. Neurology 55:1719–1721.
Shaikh, A. Y., and Martin, L. J. (2002). DNA base-excision repair enzyme apurinic/apyrimidinic endonuclease/redox factor-1 is increased and competent in the brain and spinal cord of individuals with amyotrophic lateral sclerosis. Neuromol. Med. 2:47–60.
Singh, N. P., McCoy, M. T., Tice, R. R., and Schnider, E. L. (1988). A simple technique for quantification of low levels of DNA damage in individual cells. Exp. Cell. Res. 175:184–191.
Stadtman, E. (1993). Oxidation of free amino acid residues in proteins by radiolysis and by metal catalysed reactions. Annu. Rev. Biochem. 62:797–821.
Tice, R. R., Strauss, G. H., and Peters, W. P. (1992). High-dose combination alkylating agents with autologous bone-marrow support in patients with breast cancer: Preliminary assessment of DNA damage in individual peripheral blood lymphocytes using the single cell gel electrophoresis assay. Mutat. Res. 271:101–113.
Whitmarsh, A., and Davis, R. (1996). Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:589–607.
Wong, A., Yang, J., Cavadini, P., Gellera, C., Lonnerdal, B., Taroni, F., and Cortopassi, G. (1999). The Friedreich's ataxia mutation confers cellular sensitivity to oxidant stress which is rescued by chelators of iron and calcium and inhibitors of apoptosis. Hum. Mol. Genet. 8:425–430.
Xia, M., Dickens, J., Raingeaud, R., Davis, J., and Greenberg, M. E. (1995). Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1331.
Zhang, Y., Dawson, V. L., and Dawson, T. M. (2000). Oxidative stress and genetics in the pathogenesis of Parkinson's disease. Neurobiol. Dis. 7:240–250.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Milano, A., Gesualdi, N.M., Teperino, R. et al. Oxidative DNA Damage and Activation of c-Jun N-Terminal Kinase Pathway in Fibroblasts from Patients with Hereditary Spastic Paraplegia. Cell Mol Neurobiol 25, 1245–1254 (2005). https://doi.org/10.1007/s10571-005-8501-2
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10571-005-8501-2